Pharmacokinetics of azithromycin in rabbit lacrimal glands and conjunctiva

Ophthalmic Research

Volumn 31, Issue 1, 1999, Pages 47-52

  Karcioglu, Zeynel A ^a,c   Ahmed, Wael S ^a   Raines, Dale ^b   El Yazigi, Adnan ^b  

^a KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Azithromycin levels; Chlamydia; Drug levels; Lacrimal gland; Trachoma

Indexed keywords

AZITHROMYCIN; DRUG; ANTIINFECTIVE AGENT;

ANIMAL TISSUE; ARTICLE; CHLAMYDIA TRACHOMATIS; CONJUNCTIVA; CONTROLLED STUDY; DRUG TISSUE LEVEL; ELECTROCHEMICAL DETECTION; FEMALE; HARDER GLAND; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACRIMAL GLAND; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA; PRIORITY JOURNAL; RABBIT; TRACHOMA; ANIMAL; COMPARATIVE STUDY; FOLLOW UP; LACRIMAL APPARATUS; METABOLISM; RANDOMIZATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONJUNCTIVA; FEMALE; FOLLOW-UP STUDIES; LACRIMAL APPARATUS; RABBITS; RANDOM ALLOCATION;

EID: 0032589626     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055512     Document Type: Article

References (31)

1. Bright GM, Nagel AA, Bordner J, Desai K, Dibrino JN, Nowakowska J, Vincent L, Watrous RM, Sciavolino FC, English AR: Synthesis, in vitro and in vivo activity of novel 9-deoxo-9α-AZA-9α homoeryhtromycin A derivatives: A new class of macrolide antibiotics, the azalides. J Antibiot (Tokyo) 1988;41:1029-1047.
2. Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R: Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother 1987;31:1939-1947.
3. Walsh M, Kappus EW, Quinn TC: In vitro evaluation of CP-62,993, erythromycin, clindamyin, and tetracycline against Chlamydia trachomatis. Antimicrob Agents Chemother 1987;31:811-812.
4. Williams JD: Spectrum of activity of azithromycin. Eur J Clin Microbiol Infect Dis 1991;10:813-820.
5. Girard D, Bergeron JM, Milisen WB, Retsema JA: Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses. J Antimicrob Chemother 1993;31(suppl E):17-28.
6. Neu HC: Clinical microbiology of azithromycin. Am J Med 1991;91: 12S-18S.
7. Genc M, Mardh A: A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996;124:1-7.
8. Pechère JC: The activity of azithromycin in animal models of infection. Eur J Clin Mircobiol Infect Dis 1991;10:821-827.
9. Peters DH, Friedel HA, McTavish D: Azithromycin : A review of its antimicrobial activity, pharmacokinetic properties and clinical efficiacy. Drugs 1992;44:750-799.
10. O'Day DM, Head WS, Foulds G, Robinson RD, Williams TE, Ferraina RA: Ocular pharmacokinetics of orally administered azithromycin in rabbits. J Ocul Pharmacol 1994;10: 633-641.
11. Sullivan DA: Hormonal influence on the secretory immune system of the eye; in Freier S (ed): the Neuroendocrine-Immune Network. Boca Raton, CRC Press, 1990, pp 199-237.
12. Wieczorek R, Jakobiec FA, Sacks EH, Knowles DM: The immunoarchitecture of the normal human lacrimal gland: Relevancy for understanding pathologic conditions. Ophthalmology 1988;95:100-109.
13. Fouda HG, Schneider RP: Quantitative determination of the antibiotic azithromycin in human serum by high-performance liquid chromatography (HPLC)-atmospheric pressure chemical ionization mass spectrometry: Correlation with a standard HPLC-electrochemical method. Ther Drug Monit 1995;17:179-183.
14. Riedel KD, Wildfeuer A, Laufen H, Zimmermann T: Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples. J Chromatogr 1992;576:358-362.
15. Shepard RM, Duthu GS, Ferraina RA, Mullins MA: High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues. J Chromatogr 1991;565:321-337.
16. Tabbara KF: Chlamydia: Trachoma and inclusion conjunctivitis; in Tabbara KF, Hyndiuk (eds): Infections of the Eye. Boston, Little Brown, 1996, pp 433-451.
17. Harrison HR, English MG, Lee CK, Alexander ER: Chlamydia trachomatis infant pneumonitis: Comparison with matched controls and other infant pneumonitis. N Engl J Med 1978;298:702-708.
18. Schachter J, Lum L, Gooding CA, Ostler B: Pneumonitis following inclusion blennorrhea. J Pediatr 1975; 87:779-780.
19. Viswalingam ND, Wishart MS, Woodland RM: Adult chlamydial ophthalmia (paratrachoma). Br Med Bull 1983;39:123-127.
20. Malaty R, Zaki S, Said ME, Vastine DW, Dawson DW, Schachter J: Extraocular infections in children in areas with endemic trachoma. J Infect Dis 1981;143:853-857.
21. Dawson CR, Schechter J, Stephens RS: Chlamydial keratoconjunctivitis; in Pepose JS, Holland GN, Wilhelmus KP (eds): Ocular Infection Immunology. Mosby, St Louis 1996, pp 818-829.
22. Dawson CR: Lids, conjunctiva, and lacrimal apparatus: Eye infections with Chlamydia. Arch Ophthalmol 1975;93:854-862.
23. Viswalingam ND, Darougar S, Yearsley P: Oral doxycycline in the treatment of adult chlamydial ophthalmia. Br J Ophthalmol 1986;70: 301-304.
24. Darougar S, Viswalingam ND, El-Sheikh H, Hunter PA, Yearsley P: A double-blind comparison of topical therapy of chlamydial ocular infection (TRIC infection) with rifampicin or chlortetracycline. Br J Ophthalmol 1981;65:549-552.
25. Ridgway GL: Antimicrobial chemotherapy of chlamydial infection: Where next? Eur J Clin Microbiol 1986;5:550-553.
26. Scieux C, Bianchi A, Chappey B, Vassias I, Perol Y: In vitro activity of azithromycin against Chlamydia trachomatis. J Antimicrob Chemother 1990;25(suppl A):7-10.
27. Tarizzo ML: Chemotherapy of trachoma. WHO Chronicle 1972;26: 99-101.
28. Bailey RL, Arullendran P, Whittle HC, Mabey DC: Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993;342:453-456.
29. Karcioglu ZA, Jabak MH, Choudhury AH, El-Yazigi A: Pharmacokinetics of azithromycin in active trachoma patients. Ophthalmology 1998;105:658-661.
30. Slaney L, Chubb H, Ronald A, Brunham R: In vitro activity of azithromycin, erythromycin, ciprofloxacin, and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi and Chlamydia trachomatis. J Antimicrob Chemother 1990; 25(suppl A):1-5.
31. Jaruratanasirikul S, Hortiwakul R, Tantisarasart T, Phuenpathom N, Tussanasunthornwong S: Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob Agents Chemother 1996;40: 825-826.